Acurx Pharmaceuticals, Inc. announces closing of up to $7.1 million registered direct offering priced at-the-market under Nasdaq rules

Published: 2026-04-16 16:45:45 ET ACXP

Published on 04/16/2026 at 04:45 pm EDT